MOLECULAR ANALYSIS OF LANGER-GIEDION SYNDROME
Langer-Giedio 综合征的分子分析
基本信息
- 批准号:2403235
- 负责人:
- 金额:$ 19.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-09-01 至 1999-08-31
- 项目状态:已结题
- 来源:
- 关键词:Mus musculus achondroplasia bone development carcinogenesis chromosome deletion congenital skeletal disorder cytogenetics developmental genetics family genetics gene expression gene rearrangement gene targeting genetic polymorphism genetically modified animals human genetic material tag human tissue in situ hybridization linkage mapping molecular pathology northern blottings nucleic acid sequence phenotype polymerase chain reaction pulsed field gel electrophoresis southern blotting
项目摘要
DESCRIPTION (Adapted from the Investigator's Abstract): Langer-Giedion
syndrome is characterized by cone-shaped epiphyses in the hand, multiple
cartilaginous exostoses, shortness of stature, and characteristic
craniofacial abnormalities, and mental retardation. The clinical features
of Langer-Giedion syndrome are essentially identical to those of
trichorhinophalangeal syndrome type I except that the latter does not
include multiple exostoses and rarely includes mental retardation. The
exostoses found in LGS are essentially identical to those seen in hereditary
multiple exostoses, an autosomal dominant disorder characterized by
multiple, cartilage-capped exostoses (benign tumors) on the juxtaepiphyseal
regions of enchondral bones. The long term goal of this research project is
the complete characterization at the molecular level of the genes which are
responsible for the phenotypes associated with the Langer-Giedion syndrome
and the related syndromes hereditary multiple exostoses and
trichorhinophalangeal syndrome type 1. This application encompasses the
following three specific aims which are directed at our long term goal.
First is to isolate and characterize the genes located in the LGS region
including TRPSI and any genes that may be involved in normal mental
function. Second, isolate and characterize the gene for EXT2 present on
chromosome 11 and look for clues as to how its function is related to EXT1.
Third, use the mouse as a model system to analyze the role of EXT1 in bone
development and tumorigenesis. Characterize the temporal and spatial
pattern of EXT1 expression in the mouse using both RNA blot and in situ
hybridization techniques determine the role this gene plays in vivo by
analyzing mice with a null mutation in the EXT1 gene. The genes involved in
the pathology of Langer-Giedion syndrome are likely to be involved in the
normal development of bone and connective tissues and of normal mental
capabilities. Understanding the functions of these genes may give us
insights into these important developmental processes as well as tumor
suppression. Molecular analysis of the Langer-Giedion genes will be an
essential step towards a detailed understanding of their functions.
描述(改编自研究者摘要):Langer-Giedion
综合征的特点是锥形骨骺在手中,多个
软骨性外生骨疣,身材矮小,
颅面畸形和智力迟钝 的临床特点
Langer-Giedion综合征的发病率与
毛鼻指综合征I型,除了后者不
包括多发性外生骨疣,很少包括智力迟钝。 的
在LGS中发现的外生骨疣基本上与在遗传性
多发性外生骨疣,一种常染色体显性遗传疾病,
多发性,软骨帽外生骨疣(良性肿瘤)在近骺
软骨内骨骼的区域。 本研究项目的长期目标是
基因在分子水平上的完整表征,
与Langer-Giedion综合征相关的表型
以及遗传性多发性外生骨疣的相关综合征,
发鼻指综合征1型。 此应用程序包括
这三个目标都是针对我们的长远目标。
首先是分离和鉴定位于LGS区域的基因
包括TRPSI和任何可能与正常精神
功能 第二,分离并表征存在于大肠杆菌中的EXT 2基因。
11号染色体,并寻找其功能如何与EXT 1相关的线索。
第三,以小鼠为模型系统,分析EXT 1在骨中的作用
发育和肿瘤发生。 描述时间和空间
使用RNA印迹和原位杂交的小鼠中EXT 1表达模式
杂交技术确定了该基因在体内的作用,
分析EXT 1基因无效突变的小鼠。 相关基因
Langer-Giedion综合征的病理学可能涉及
骨骼和结缔组织以及正常智力的正常发育
能力的 了解这些基因的功能可能会给我们
深入了解这些重要的发育过程以及肿瘤
镇压 对Langer-Giedion基因的分子分析将是一项重要的研究。
这是深入了解其功能的重要一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAN E WELLS其他文献
DAN E WELLS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAN E WELLS', 18)}}的其他基金
Hereditary Multiple Exostoses:Insights Into Pathogenesis
遗传性多发性外生骨疣:发病机制的见解
- 批准号:
7059235 - 财政年份:2005
- 资助金额:
$ 19.22万 - 项目类别:
Hereditary Multiple Exostoses: Insights Into Pathogenesis
遗传性多发性外生骨疣:发病机制的见解
- 批准号:
7144464 - 财政年份:2005
- 资助金额:
$ 19.22万 - 项目类别:
MOLECULAR ANALYSIS OF LANGER-GIEDION SYNDROME
Langer-Giedio 综合征的分子分析
- 批准号:
3329601 - 财政年份:1993
- 资助金额:
$ 19.22万 - 项目类别:
MOLECULAR ANALYSIS OF LANGER-GIEDION SYNDROME
Langer-Giedio 综合征的分子分析
- 批准号:
2200801 - 财政年份:1993
- 资助金额:
$ 19.22万 - 项目类别:
MOLECULAR ANALYSIS OF LANGER-GIEDION SYNDROME
Langer-Giedio 综合征的分子分析
- 批准号:
2673650 - 财政年份:1993
- 资助金额:
$ 19.22万 - 项目类别:
MOLECULAR ANALYSIS OF LANGER-GIEDION SYNDROME
Langer-Giedio 综合征的分子分析
- 批准号:
2200799 - 财政年份:1993
- 资助金额:
$ 19.22万 - 项目类别:
MOLECULAR ANALYSIS OF LANGER-GIEDION SYNDROME
Langer-Giedio 综合征的分子分析
- 批准号:
2200800 - 财政年份:1993
- 资助金额:
$ 19.22万 - 项目类别:
相似海外基金
Exploring the genetic background of normal facial variation to dissect disease expressivity, using achondroplasia as a model.
以软骨发育不全为模型,探索正常面部变异的遗传背景,以剖析疾病的表现力。
- 批准号:
486257 - 财政年份:2022
- 资助金额:
$ 19.22万 - 项目类别:
Studentship Programs
Development of therapeutic drugs fro achondroplasia-Examination of FGFR3 inhibitory effects of meclizine hydrochloride
软骨发育不全治疗药物的研制——盐酸美其嗪对FGFR3抑制作用的考察
- 批准号:
21H03063 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the relationship between obesity and type 2 diabetes in achondroplasia
阐明肥胖与软骨发育不全中 2 型糖尿病之间的关系
- 批准号:
19K23996 - 财政年份:2019
- 资助金额:
$ 19.22万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Examination of obesity and insulin resistance for patient cohort and disease-specific iPS cells with achondroplasia
检查患有软骨发育不全的患者群体和疾病特异性 iPS 细胞的肥胖和胰岛素抵抗
- 批准号:
18K07877 - 财政年份:2018
- 资助金额:
$ 19.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Early intervention for children with achondroplasia: self-management and self-efficacy
软骨发育不全儿童的早期干预:自我管理和自我效能
- 批准号:
26861923 - 财政年份:2014
- 资助金额:
$ 19.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8675729 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8129527 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8277448 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8476987 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
7987228 - 财政年份:2010
- 资助金额:
$ 19.22万 - 项目类别: